108 related articles for article (PubMed ID: 207172)
1. Regulation of phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
[No Abstract] [Full Text] [Related]
2. Phospholipase A2 and platelet aggregation.
Blackwell GJ
Adv Prostaglandin Thromboxane Res; 1978; 3():137-42. PubMed ID: 655004
[No Abstract] [Full Text] [Related]
3. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecases P
Biochem Biophys Res Commun; 1977 Jun; 76(3):828-35. PubMed ID: 197928
[No Abstract] [Full Text] [Related]
4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
[No Abstract] [Full Text] [Related]
6. Contribution of arachidonic acid metabolites to atherosclerosis.
Dembińska-Kieć A; Gryglewski RJ
Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
[TBL] [Abstract][Full Text] [Related]
7. Lithium inhibits adenylate cyclase of human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C
Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
[TBL] [Abstract][Full Text] [Related]
8. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
9. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
11. The role of prostaglandins in platelet function.
Burch JW; Majerus PW
Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883
[No Abstract] [Full Text] [Related]
12. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
Wilson NH; Armstrong RA; Jones RL
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
[No Abstract] [Full Text] [Related]
13. A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets.
Fujimori T; Harada K; Saeki T; Kogushi M; Yoshimura T; Katayama K
Jpn J Pharmacol; 1991 Jan; 55(1):81-91. PubMed ID: 1645815
[TBL] [Abstract][Full Text] [Related]
14. The role of phospholipase C in platelet responses.
Lapetina EG; Siess W
Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
[TBL] [Abstract][Full Text] [Related]
15. The role of prostacyclin in vascular tissue.
Moncada S; Vane JR
Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
[No Abstract] [Full Text] [Related]
17. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
Lagarde M; Guichardant M; Ghazi I; Dechavanne M
Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action of antiplatelet medication].
Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
[No Abstract] [Full Text] [Related]
19. [Mechanism of platelet aggregation inhibition].
Abiko Y; Ashida S
Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
[No Abstract] [Full Text] [Related]
20. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
Lösche W; Michel E; Thielmann K; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
